A kind of medicine compound muscle patch

Abstract

The utility model discloses a drug-compound muscle patch, which is composed of an elastic layer, an adhesive layer and a release layer from the outside to the inside. The surface of the adhesive layer close to the release layer is arranged with water-shaped grooves, and the grooves are filled with drugs. The muscle patch produces mechanical and neurophysiological effects on the body surface through its structure, and is used for therapeutic purposes such as protecting the musculoskeletal system and promoting motor function. In particular, a double-layer patch is arranged in the adhesive layer, and the patch is fixed by points. After the muscle patch is stretched, the distance between the patches changes, and the changes in the exposed part of the lower patch are observed from the outside of the transparent elastic layer to judge the stretching and failure state of the muscle patch. The drug-compound muscle patch of the utility model contains an analgesic drug, combines the dual advantages of physical support and drug treatment of traditional muscle patches, and provides better treatment effects. In particular, by setting tear lines of various shapes, the product can adapt to different usage scenarios and user needs.

Description

Technical Field

[0001] The utility model relates to the technical field of medical auxiliary appliances, and in particular to a pharmaceutical composite muscle patch. Background Art

[0002] The medicated compound kinesio patch, or kinesio patch technology, is a treatment method that uses special elastic kinesio patches. This technology produces mechanical and neurophysiological effects by attaching kinesio patches to the body surface in a specific way, thereby protecting the musculoskeletal system, promoting motor function or other therapeutic purposes. Kinesio patch technology has been widely used in the fields of rehabilitation medicine and sports medicine.

[0003] Kinesio taping originated in the 1870s and quickly gained attention. Kinesio taping is used not only by athletes but also in neurology and pediatric rehabilitation.

[0004] The mechanism of action of the kinesio patch is to utilize the mechanical interaction between the elastic force of the kinesio patch and the human body surface. In clinical application, the greater the tension, the better. According to Hooke's law, once the tension exceeds the elastic limit of the kinesio patch, the elasticity of the kinesio patch is destroyed, and the retraction ability decreases or even disappears. Although it can be used for fixation, fascia guidance, etc., the effect is not as good as the white patch (it uses non-elastic kinesio patch, which is mainly used for bandaging and protection. Compared with the kinesio patch, it has a better fixation and braking effect). Therefore, special attention should be paid to the selection of tension in clinical application. Moderate tension can produce corresponding therapeutic effects, but excessive tension can cause the kinesio patch to deform and the retraction force to decrease. The kinesio patch currently used in the industry has no obvious indication for judging whether its elastic force has failed. In addition, it does not contain drugs. Non-professionals cannot effectively utilize the effects of the kinesio patch due to lack of experience when using it for the first time (the tension exceeds the elastic limit of the kinesio patch and makes it ineffective).

[0005] Therefore, there is an urgent need for a pharmaceutical composite muscle patch containing an analgesic agent with better therapeutic effect. Utility Model Content

[0006] The purpose of the utility model is to overcome the above-mentioned deficiencies in the prior art and to provide an improved pharmaceutical composite muscle patch.

[0007] The technical solution adopted by the utility model to solve the above-mentioned problem is: a pharmaceutical composite muscle patch, which is composed of an elastic layer, an adhesive layer and a release layer from the outside to the inside, the elastic layer is transparent in the middle, and the adhesive layer below the transparent part is arranged with two layers of patches, and the patches are fixed to the elastic layer in a point-fixed manner. The two layers of patches are arranged alternately up and down, and when the elastic layer is not subjected to force and viewed from the outside to the inside, part of the area of ​​the lower layer of patches is blocked by the upper layer of patches, and this blocked area includes an active part and an ineffective part.

[0008] Preferably, the failure portion is marked in red, and the action portion is marked in orange, yellow and blue in descending order according to the tensile force on the elastic layer.

[0009] Preferably, the surface of the adhesive layer close to the release layer is provided with water-shaped grooves, and the grooves are filled with medicine.

[0010] Preferably, the groove is sealed by a layer of isolation membrane, and the isolation membrane is made of water-soluble material.

[0011] Preferably, the outer surface of the elastic layer is provided with a tear line, and the tear line has different shapes and sizes according to the different shapes of the muscle joints.

[0012] Preferably, the elastic layer is made of waterproof stretch fabric, the waterproof stretch fabric is provided with a variety of colors, and the transparent part of the elastic layer is made of thermoplastic rubber.

[0013] Preferably, the release layer is wider than the adhesive layer, and a serrated structure is provided on both sides of the release layer.

[0014] Preferably, the adhesive layer is made of heat-sensitive adhesive.

[0015] Compared with the prior art, the utility model has the following advantages and effects: the pharmaceutical compound muscle patch of the utility model contains an analgesic agent, which can provide additional therapeutic effects, especially in relieving local pain; a double-layer patch is arranged in its adhesive layer, and the patch is fixed by a point. After the muscle patch is stretched, the distance between the patches changes, and the changes in the exposed part of the lower patch (the active part: orange, yellow and blue and the ineffective part: red) can be observed from the outside of the transparent elastic layer to judge the stretching and ineffective state of the muscle patch. The utility model combines the dual advantages of physical support and drug treatment of traditional muscle patches, taking into account the convenience, safety and therapeutic effects of users, especially the stretching indication provided by color changes, and tear lines of various shapes, so that the product can adapt to different usage scenarios and user needs. BRIEF DESCRIPTION OF THE DRAWINGS

[0016] Figure 1 - Figure 2 It is a schematic diagram of the structure of a pharmaceutical composite muscle patch according to an embodiment of the utility model.

[0017] Figure 3 It is a top view of a pharmaceutical composite muscle patch according to an embodiment of the utility model.

[0018] Figure 4 This is a cross-sectional view AA of a pharmaceutical composite muscle patch in use according to an embodiment of the utility model.

[0019] Figure 5This is a cross-sectional view BB of a pharmaceutical composite muscle patch during stretching according to an embodiment of the utility model.

[0020] Figure 6 It is a partially enlarged schematic diagram of the patch of the embodiment of the utility model.

[0021] Figure 7 It is a schematic structural diagram of the tear line of an embodiment of the utility model.

[0022] Figure numbers: Skin patch main body 1, elastic layer 2, transparent part 21, adhesive layer 3, groove 31, isolation film 32, medicine 33, release layer 4, serrated structure 41, patch 5, active part 51, blue area 511, yellow area 512, orange area 513, failure part 52, tear line 6, skin 7, wrinkle 71. DETAILED DESCRIPTION

[0023] The present invention will be further described in detail below with reference to the accompanying drawings and through examples. The following examples are provided to explain the present invention, but the present invention is not limited to the following examples.

[0024] Embodiment 1:

[0025] See also Figure 1 - Figure 6 In this embodiment, a compound muscle patch of medicine 33 is involved, which is specifically used to exert its mechanical and neurophysiological effects through the protection of the musculoskeletal system, the promotion of motor function or other therapeutic purposes. This muscle patch technology is widely used in the fields of rehabilitation medicine and sports medicine, especially in the treatment of musculoskeletal diseases and the fields of neurological and pediatric rehabilitation. Specifically, it includes: from the outside to the inside, it is composed of an elastic layer 2, an adhesive layer 3 and a release layer 4. The elastic layer 2 is transparent in the middle, and the adhesive layer below the transparent part 21 is embedded with two layers of patches 5 and fixed by points. The two layers of patches 5 are arranged in an alternating manner, and when viewed from the outside of the elastic layer 2 vertically to the inside, there is a shielding area on the lower layer of the patch 5, and the shielding area includes an action part 51 and an ineffective part 52.

[0026] Specifically, in this embodiment, the release layer 4 needs to be peeled off when in use, and the resilience of the elastic layer 2 is used to lift the skin 7 after pasting to produce wrinkles 71, thereby increasing the gap between the skin 7 and the subcutaneous tissue, thereby affecting the flow direction of the subcutaneous fascia tissue, allowing the fascia system to have sufficient permeability and circulation, and promoting lymph and blood circulation. When the patch 5 is stretched, the distance between the patches 5 increases (since the patch 5 is fixed by points, it will not be stretched), the shielding area decreases during the stretching process, and the action part 51 of the lower patch 5 is gradually exposed. The patch 5 is observed through the transparent part 21 of the elastic layer 2: when the action part 51 of the lower patch 5 can be observed and the failure part 52 is not reflected (the patch is stretched to less than 160% of its original length), it indicates that the tension does not exceed the elastic limit of the patch, its retraction ability is retained, and it has a corresponding therapeutic effect; when the failure part 52 of the lower patch 5 is exposed (the patch is stretched to more than 160% of its original length), it indicates that the tension at this time has exceeded the elastic limit of the elastic layer 2, the elastic layer 2 is plastically deformed, the retraction force decreases, and the pain relief effect of the patch will be reduced. This allows users to intuitively judge whether the stretching degree of the patch is appropriate, thereby ensuring the therapeutic effect and avoiding failure due to excessive stretching.

[0027] The failure part 52 is in red, and the action part 51 is in orange, yellow and blue as marks in order according to the tension of the elastic layer 2 from large to small. In this embodiment, the failure part 52 indicates that the muscle patch is stretched to more than 160% of its original length, which has exceeded the elastic limit and may cause plastic deformation and decreased retraction force; the orange area 513 indicates that the muscle patch is stretched to 140% to 160% of its original length and is in a state close to the elastic limit; the yellow area 512 indicates that the muscle patch is stretched to 120% to 140% of its original length and is in a medium tension state; the blue area 511 indicates that the muscle patch is stretched to 100% to 120% of its original length and is in a lighter tension state. The above color coding design is intended to provide simple and easy-to-understand visual guidance. Users can stretch the muscle patch to different length ratios (stretched length / original length) so that the muscle patch forms different stretching forces while maintaining the effectiveness of the patch to meet the user's usage needs.

[0028] The adhesive layer 3 is provided with water-patterned grooves 31 on the surface of the side close to the release layer 4, and the grooves 31 are filled with medicine 33. The grooves 31 become wider after being stretched, and the small wrinkles 71 produced by the skin 7 are wrapped therein, and the analgesic medicine 33 in the grooves 31 penetrates through the small wrinkles 71, which can effectively relieve local pain. Compared with the traditional muscle patch without medicine, it has a better therapeutic effect.

[0029] The groove 31 is sealed by a layer of isolation film 32. The closed groove 31 can prevent the medicine 33 from being contaminated by external pollutants before use. When the muscle patch is stretched, the isolation film 32 is torn, and the medicine 33 in the groove 31 is slowly released. The analgesic medicine 33 can gradually penetrate into the skin 7 after the muscle patch is stretched and applied. The isolation film 32 is made of water-soluble material (i.e., water-soluble film). The concentration of the analgesic medicine 33 will gradually decrease with the use time of the muscle patch, and the speed of penetration into the skin 7 will also decrease. When in use, since the human skin 7 will secrete sweat, the isolation film 32 will decompose after encountering sweat, so that the remaining analgesic medicine 33 can continue to penetrate into the skin 7, so that the analgesic medicine 33 continues to work. At the same time, the isolation film 32 that is not torn during stretching can also be decomposed, and the medicine in the groove 31 sealed by it will be released and fully utilized.

[0030] See also Figure 7 The outer surface of the elastic layer 2 is provided with a tear line 6, and the tear line 6 has different shapes and sizes according to the different shapes of the muscle joints. The muscle patch body 1 is a long strip, which can be separated into I-type, Y-type, X-type and claw-type through the tear line 6.

[0031] Among them: See Figure 7 (a) Type I is the most commonly used muscle patch shape (its tear line 6 is closed along the long strip outer contour and becomes I-shaped after being peeled off), which can support and relax muscles, lift the pain point, relieve pain, and provide maximum protection and fixation, such as soft tissue injuries;

[0032] See also Figure 7 (b) Y-type (its tear line 6 is closed along the long strip outer contour, and a single tear line is provided on one side along the length direction, and one end of the tear line does not intersect with the outer contour, and it is Y-shaped after being peeled off and unfolded) is often used to adjust muscle tension, promote circulation and metabolism, and is suitable for relaxing tight and swollen muscles (stretching and relaxing muscles, often used for muscles in a large area, such as the gastrocnemius area);

[0033] See also Figure 7 (c) X-shaped (its tear line 6 is closed along the outer contour of the long strip, and there are two tear lines on both sides along the length direction. The two tear lines do not intersect at the opposite ends, and after being peeled off and unfolded, it forms an X shape) is often used to promote blood circulation and metabolism at the fixed end position, and has an analgesic effect (by draining the blood and lymph around to the center);

[0034] See also Figure 7(d) Claw type (its tear line 6 is closed along a circle along the long strip outer contour, and a number of tear lines are provided on one side along the length direction. One end of these tear lines does not intersect with the outer contour, and it is claw-shaped after being peeled off and unfolded) is often used to promote local tissue circulation, relax tissue tension, improve tissue fluid retention, and have analgesic effects. For example, it has the effect of reducing swelling when applied to the skin of the ankle joint.

[0035] The above-mentioned muscle patch body 1 has the following characteristics:

[0036] (1) The elastic layer 2 is made of waterproof elastic fabric. The elastic layer 2 has appropriate elasticity, adhesive on one side, and has a certain degree of waterproofness. The adhesive surface has a "fingerprint" or "water ripple" structure. Its special material and structure are conducive to the patch pulling up the skin 7 or subcutaneous tissue from different directions to achieve the purpose of treatment.

[0037] (2) The elastic layer 2 is in a variety of colors. Traditional skin patches mainly use four colors: black, magenta, cyan and light brown (skin color). In recent years, more personalized colors and patterns have appeared. Although there is no essential difference in the material of patches of different colors, there may be a color principle effect. Based on psychological effects or placebo effects, the impact of color on users cannot be ignored.

[0038] (3) The adhesive layer 3 is made of heat-sensitive adhesive. Therefore, after the patch is applied, the patch can be rubbed repeatedly with the hand in the direction of application to make it more firmly bonded to the skin 7. The characteristics of heat-sensitive adhesive are utilized to activate the adhesive layer through the temperature change caused by body temperature or external friction, thereby providing stronger adhesion and more stable support.

[0039] (4) The release layer 4 is wider than the adhesive layer 3 and has serration structures 41 on both sides. The serration structures 41 provide a better gripping point, making it easier for users to peel off the release layer 4.

[0040] The above contents described in this specification are merely examples of the present utility model. Those skilled in the art of the present utility model may make various modifications or additions to the specific embodiments described, or replace them in similar ways, as long as they do not deviate from the contents of the present utility model specification or exceed the scope defined in the claims, they shall all fall within the protection scope of the present utility model.

Claims

1. A pharmaceutical compound muscle patch, characterized in that: From the outside to the inside, it is composed of an elastic layer, an adhesive layer and a release layer. The elastic layer is transparent in the middle, and two layers of patches are arranged on the adhesive layer below the transparent part. The patches are fixed to the elastic layer in a point-fixed manner. The two layers of patches are arranged alternately up and down, and when the elastic layer is not under force and viewed from the outside to the inside, part of the area of ​​the lower layer of patches is blocked by the upper layer of patches, and this blocked area includes an active part and an ineffective part.

2. The pharmaceutical composite muscle patch according to claim 1, characterized in that: The failure portion is marked in red, and the action portion is marked in orange, yellow and blue in descending order according to the tensile force on the elastic layer.

3. The pharmaceutical composite muscle patch according to claim 1, characterized in that: The surface of the adhesive layer close to the release layer is arranged with water-shaped grooves, and the grooves are filled with medicine.

4. The pharmaceutical composite muscle patch according to claim 3, characterized in that: The groove is sealed by a layer of isolation film, and the isolation film is made of water-soluble material.

5. The pharmaceutical composite muscle patch according to claim 1, characterized in that: The outer surface of the elastic layer is provided with tear lines, and the tear lines are provided with different shapes and sizes according to the different shapes of muscle joints.

6. The pharmaceutical composite muscle patch according to claim 5, characterized in that: The elastic layer is made of waterproof elastic fabric, which has multiple colors, and the transparent part of the elastic layer is made of thermoplastic rubber.

7. The pharmaceutical composite muscle patch according to claim 1, characterized in that: The release layer is wider than the adhesive layer, and a serrated structure is provided on both sides of the release layer.

8. The pharmaceutical composite muscle patch according to claim 1, characterized in that: The adhesive layer adopts heat-sensitive pressure adhesive.

Images